The Seamaty SD1 represents a cutting-edge advancement in laboratory diagnostics, combining microfluidic technology with biochip innovation to deliver rapid, accurate, and convenient biochemical analysis. This compact analyzer is engineered to transform point-of-care testing across healthcare settings.

Working Principle

The SD1 operates through a streamlined three-step process:

1.Sample Application: A minimal sample volume (90-120μL of whole blood, plasma, or serum) is applied to a disposable microfluidic chip.
2.Reaction & Detection: Pre-loaded reagents on the chip react with the sample, generating optical signals through absorption spectroscopy and transmission turbidimetry.

3.Analysis & Output: The built-in 4.3″ IPS touchscreen automatically processes signals using endpoint, kinetic, and fixed-time methodologies, delivering results within 12 minutes.

Key Features

  • Compact Design:

    • Dimensions: 200mm(W) × 252mm(D) × 299mm(H)
    • Weight: 4.6kg (1/20th the size of traditional analyzers)
    • Space-saving footprint ideal for mobile clinics and small labs

  • Operational Simplicity:

    • No sample preprocessing or dilution required
    • Intuitive Android-based interface with multilingual support
    • 3-step workflow: Add sample → Insert reagent disc → Read results

  • High Performance:

    • 0.001Abs resolution with 8-wavelength detection (340-850nm)
    • Real-time internal quality control (IQC) system
    • Zero cross-contamination via single-use reagent discs

  • Advanced Capabilities:

    • Stores up to 500,000 test records
    • Built-in thermal printer and LIS connectivity
    • 7″ capacitive touchscreen with cloud-computing support

Applications

The SD1 excels in diverse clinical environments:

  • Core Lab Testing:

    • Liver/kidney function panels
    • Cardiac biomarkers
    • Lipid profiles & electrolytes
    • Glucose monitoring

  • Critical Care:

    • Emergency department testing
    • Field diagnostics for disaster relief
    • Veterinary applications (SMT-120VP variant)

  • Point-of-Care:

    • Physician offices
    • Community health centers
    • Remote healthcare initiatives

Future Prospects

As microfluidic technology evolves, the SD1 platform is positioned for continued innovation:

  • Expanded Menus: Development of new reagent discs for specialized biomarkers
  • AI Integration: Machine learning algorithms for predictive diagnostics
  • Global Health: Adaptation for low-resource settings through solar-powered variants

The SD1 exemplifies the convergence of precision engineering and clinical practicality, offering a scalable solution for modern healthcare challenges while maintaining CE, ISO13485, and China FDA (川械注准20192220073) certifications. Its 2500-hour halogen lamp lifespan and 1-year reagent stability further underscore its reliability for continuous operation in demanding environments.